(BPMC) Blueprint Medicines - Performance 17.6% in 12m
BPMC performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
18.01%
#20 in Peer-Group
Rel. Strength
63.48%
#2713 in Stock-Universe
Total Return 12m
17.55%
#51 in Peer-Group
Total Return 5y
61.80%
#19 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 128.40 USD |
| 52 Week Low | 79.22 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 89.40 |
| Buy/Sell Signal +-5 | 0.81 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: BPMC (17.6%) vs XBI (-10.7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.32% | 68% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-10.6% | -8.81% | 144% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
0.71% | -3.57% | 32.5% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.36% | 31.7% | -6.18% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
2.76% | -8.64% | 0.27% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.5% | 65.3% | -5.65% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
-0.49% | 55.9% | -10.1% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.44% | 35.3% | 14.7% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: BPMC vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BPMC
| Total Return (including Dividends) | BPMC | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 0.43% | 2.27% | 4.52% |
| 3 Months | 49.34% | 6.30% | 10.43% |
| 12 Months | 17.55% | -10.68% | 14.67% |
| 5 Years | 61.80% | -26.13% | 109.23% |
| Trend Score (consistency of price movement) | BPMC | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 75.3% | 5.5% | 79.1% |
| 3 Months | 94% | 74.3% | 94.2% |
| 12 Months | 10.2% | -84.7% | 44.4% |
| 5 Years | 0.6% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th56.50 | -1.80% | -3.91% |
| 3 Month | %th87.50 | 40.48% | 35.23% |
| 12 Month | %th75.00 | 31.60% | 2.51% |
| 5 Years | %th91.00 | 119.04% | -22.67% |
FAQs
Does Blueprint Medicines (BPMC) outperform the market?
Yes,
over the last 12 months BPMC made 17.55%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.68%.
Over the last 3 months BPMC made 49.34%, while XBI made 6.30%.
Performance Comparison BPMC vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
BPMC vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.7% | -4.1% | 40.9% | 3% |
| US NASDAQ 100 | QQQ | -1.3% | -4.2% | 39.7% | 3% |
| German DAX 40 | DAX | -0% | 1.5% | 29.4% | -11% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.8% | -3.7% | 40% | -0% |
| Hongkong Hang Seng | HSI | 0% | -5.6% | 23.2% | -18% |
| India NIFTY 50 | INDA | -1.8% | -2% | 42.6% | 17% |
| Brasil Bovespa | EWZ | -2.8% | -7.1% | 18% | 4% |
BPMC vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -2.3% | -5.6% | 35.8% | -10% |
| Consumer Discretionary | XLY | -1.2% | -1.6% | 48.1% | -3% |
| Consumer Staples | XLP | -0.7% | 0.8% | 41.3% | 7% |
| Energy | XLE | -0.6% | -3.9% | 47% | 21% |
| Financial | XLF | -2% | -3.2% | 37.2% | -12% |
| Health Care | XLV | -2.1% | -3.1% | 47% | 22% |
| Industrial | XLI | -2% | -3.7% | 33.8% | -7% |
| Materials | XLB | -2.7% | -3.8% | 37.9% | 12% |
| Real Estate | XLRE | 1.4% | -0.3% | 42.1% | 4% |
| Technology | XLK | -1.5% | -7.5% | 38.6% | 7% |
| Utilities | XLU | -0.4% | 0% | 38.2% | -7% |
| Aerospace & Defense | XAR | -2.4% | -6.8% | 22.5% | -31% |
| Biotech | XBI | 0.9% | -1.8% | 56.4% | 28% |
| Homebuilder | XHB | -4.3% | -10.1% | 47.5% | 13% |
| Retail | XRT | -2.7% | -4% | 46.6% | 8% |
BPMC vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -1.2% | -5.87% | 51.1% | 27% |
| Natural Gas | UNG | 7.1% | 10.9% | 58.4% | 26% |
| Gold | GLD | -0.4% | 1.8% | 21.9% | -25% |
| Silver | SLV | -0.3% | -3.2% | 25.6% | -4% |
| Copper | CPER | -2.8% | -3.5% | 22.5% | 3% |
BPMC vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -0.8% | -3.1% | 44.7% | 16% |
| iShares High Yield Corp. Bond | HYG | 0.1% | -0.8% | 43% | 7% |